DNAB

Are Chamath Palihapitiya’s 4 New Biotech SPACs Worth a Look?

By Faizan Farooque, InvestorPlace Contributor
In Chamath Palihapitiya's latest SPAC empire-building move, his four new new biotech SPACs in the genomics and biotech space are making waves.

What Did the Stock Market Do Today? 3 Big Stories to Catch Up On.

By Sarah Smith, Editor-in-Chief, InvestorPlace.com
So what did the stock market do today? Investors turned to new meme stocks like XERS and watched the OGN stock spinoff launch.